Stock price when the opinion was issued
Traffic and basket sizes remain robust, as sticky inflation over the years has caused consumers to trade down. Bit of softness in Canadian economy for Q2 and Q3. Paying a premium at over 40x forward, but decent 15% growth rate. In Canada, very little competition. Very good margin expansion over time, strong FCF. Aggressively growing store count in Canada and Latin America.
Believes he heard a comment that its forward guidance is uncertain, and that could be the reason it's pulled back. Earnings are one thing, but the street looks for forward guidance because that's what's going to happen next.
Longer-term chart is a good picture. On the 1-year chart you can see consolidation. So long as the neckline (a bit over $180) holds, you're fine to own it. He always buys on a positive test of support. Everyone wants to buy as cheaply as possible, but the problem is that it could get cheaper by far. Don't buy until it proves that level of support by bouncing up.
He always thinks it's a great place to buy anniversary presents ;) It's done nothing wrong, and investors have fallen in love with it to some extent. He'd take some $$ off the table, and perhaps buy in again lower, though still likes it long term. Reaching saturation in Canada, so it's having to go abroad. International expansion can be good, but also problematic.
Worried a bit about growth in Canada slowing and not being offset enough by purchases further afield. Be mindful. Valuation of 40x PE is up there.
One trigger was valuation, trading at mid-30x PE. Look at its sourcing -- most stuff comes from China. As Canadians are getting pinched, all the discount banners are benefiting massively -- almost every metric has been sensational, but so are the valuations.
He'd love to own it, but can't come to grips with paying that valuation. A great one to add on a large pullback.
Great growth Canadian story. Seeing some more competition lately. Phenomenal company. Very well run. Still some growth runaway in Canada. It deserves the high multiple. (Analysts’ price target is $164.30)